Comment on "Exposure to air pollution is associated with an increased risk of metabolic dysfunction-associated fatty liver disease"

被引:1
|
作者
Chen, Yu-Syuan [1 ]
Hung, Yao-Min [2 ]
Wei, James Cheng-Chung [3 ,4 ,5 ]
机构
[1] Chung Shan Med Univ, Med, Taichung, Taiwan
[2] Kaohsiung Municipal United Hosp, Dept Internal Med, Kaohsiung, Taiwan
[3] Chung Shan Med Univ Hosp, Dept Allergy Immunol & Rheumatol, Taichung, Taiwan
[4] Chung Shan Med Univ, Inst Med, Coll Med, Taichung, Taiwan
[5] China Med Univ, Grad Inst Integrated Med, Taichung, Taiwan
关键词
D O I
10.1016/j.jhep.2021.12.032
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:259 / 260
页数:2
相关论文
共 50 条
  • [31] Epidemiology and diagnosis of metabolic dysfunction-associated fatty liver disease
    Fouad, Yasser
    Alboraie, Mohamed
    Shiha, Gamal
    HEPATOLOGY INTERNATIONAL, 2024, 18 (SUPPL 2) : 827 - 833
  • [32] The Efficacy of Tofogliflozin on Metabolic Dysfunction-Associated Fatty Liver Disease
    Goya, Takeshi
    Imoto, Koji
    Tashiro, Shigeki
    Aoyagi, Tomomi
    Takahashi, Motoi
    Kurokawa, Miho
    Suzuki, Hideo
    Tanaka, Masatake
    Kato, Masaki
    Kohjima, Motoyuki
    Ogawa, Yoshihiro
    GASTROENTEROLOGY INSIGHTS, 2022, 13 (01) : 20 - 26
  • [33] Association of metabolic dysfunction-associated fatty liver disease with kidney disease
    Ting-Yao Wang
    Rui-Fang Wang
    Zhi-Ying Bu
    Giovanni Targher
    Christopher D. Byrne
    Dan-Qin Sun
    Ming-Hua Zheng
    Nature Reviews Nephrology, 2022, 18 : 259 - 268
  • [34] The Janus of a disease: Diabetes and metabolic dysfunction-associated fatty liver disease
    Barrera, Francisco
    Uribe, Javier
    Olvares, Nixa
    Huerta, Paula
    Cabrera, Daniel
    Romero-Gomez, Manuel
    ANNALS OF HEPATOLOGY, 2024, 29 (04)
  • [35] Metabolic Dysfunction-Associated Steatotic Liver Disease vs. Metabolic Dysfunction-Associated Fatty Liver Disease: Which Option is the Better Choice?
    Gambardella, Maria Luisa
    Abenavoli, Ludovico
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2025, 86 (02)
  • [36] Association of metabolic dysfunction-associated fatty liver disease with kidney disease
    Wang, Ting-Yao
    Wang, Rui-Fang
    Bu, Zhi-Ying
    Targher, Giovanni
    Byrne, Christopher D.
    Sun, Dan-Qin
    Zheng, Ming-Hua
    NATURE REVIEWS NEPHROLOGY, 2022, 18 (04) : 259 - 268
  • [37] Impact of metabolic factors on risk of cardiovascular disease in nondiabetic metabolic dysfunction-associated fatty liver disease
    Min Kyu Kang
    Yu Rim Lee
    Se Young Jang
    Won Young Tak
    Young Oh Kweon
    Jeong Eun Song
    Rohit Loomba
    Soo Young Park
    Jung Gil Park
    Hepatology International, 2023, 17 : 626 - 635
  • [38] Atherosclerotic cardiovascular disease risk difference in metabolic dysfunction-associated fatty liver disease and nonalcoholic fatty liver disease
    Tamaki, Nobuharu
    Kurosaki, Masayuki
    Higuchi, Mayu
    Izumi, Namiki
    HEPATOLOGY RESEARCH, 2021, 51 (11) : 1172 - 1173
  • [39] Impact of metabolic factors on risk of cardiovascular disease in nondiabetic metabolic dysfunction-associated fatty liver disease
    Kang, Min Kyu
    Lee, Yu Rim
    Jang, Se Young
    Tak, Won Young
    Kweon, Young Oh
    Song, Jeong Eun
    Loomba, Rohit
    Park, Soo Young
    Park, Jung Gil
    HEPATOLOGY INTERNATIONAL, 2023, 17 (03) : 626 - 635
  • [40] Exposure to ambient air pollution and metabolic dysfunction-associated fatty liver disease: Findings from over 2.7 million adults in Northwestern China
    Ji, Weidong
    Cheng, Yinlin
    Tang, Shengsheng
    Gu, Kuiying
    Liao, Huipeng
    Li, Lin
    Wang, Yushan
    Yang, Bo-Yi
    Zhou, Yi
    ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY, 2024, 272